Evolution of cystic fibrosis lung function in the early years

Current Opinion in Pulmonary Medicine

Volumn 21, Issue 6, 2015, Pages 602-608

  Bush, Andrew ^a,b,c   Sly, Peter D ^d,e,f,g  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e Queensland Children's Medical Research Institute   (Australia)

^f Department of Children's Health and Environment ^*  (Australia)

^g WHO Collaborating Centre for Children's Health and Environment   (Australia)

Author keywords

Bronchiectasis; HRCT scan; newborn screening; pulmonary function tests

Indexed keywords

LEUKOCYTE ELASTASE;

COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; HUMAN; LUNG FUNCTION; LUNG INFECTION; LUNG LAVAGE; LUNG STRUCTURE; NEWBORN SCREENING; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PNEUMONIA; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPIROMETRY; UNITED STATES; LUNG; LUNG FUNCTION TEST; NEWBORN; PATHOPHYSIOLOGY;

CYSTIC FIBROSIS; HUMANS; INFANT, NEWBORN; LUNG; NEONATAL SCREENING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY FUNCTION TESTS;

EID: 84942416048     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000209     Document Type: Review

References (73)

1. Farrell PM, Kosorok MR, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med 1997; 337:963-969.
2. Robinson KA, Saldanha IJ, McKoy NA. Management of infants with cystic fibrosis: A summary of the evidence for the cystic fibrosis foundation working group on care of infants with cystic fibrosis. J Pediatr 2009; 155 (6 Suppl): S94-S105.
3. Sermet-Gaudelus I, Mayell SJ, Southern KW; European Cystic Fibrosis Society (ECFS), Neonatal Screening Working Group. Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening. J Cyst Fibros 2010; 9:323-329.
4. Farrell PM, Li Z, Kosorok MR, et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med 2003; 168:1100-1108.
5. McKay K, Wilcken E. Newborn screening for cystic fibrosis offers an advantage over symptomatic diagnosis for the long term benefit of patients: The motion for. Pediatr Respir Rev 2008; 9:290-294.
6. Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax 1995; 50:712-718.
7. Waters DL, Wilcken B, Irwig L, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999; 80:F1-F7.
8. Merelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment on long-Term clinical outcome and survival of CF patients. Eur Respir J 2001; 18:306-315.
9. Accurso FJ, Sontag MK, Wagener JS. Complications associated with symptomatic diagnosis in infants with cystic fibrosis. J Pediatr 2005; 147:s37-s41.
10. McKay KO, Waters DL, Gaskin KJ. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in New South Wales. J Pediatr 2005; 147:s47-s50.
11. Dankert-Roelse JE, te Meerman GJ, Marrtjin A, et al. Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening. J Pediatr 1989; 114:362-367.
12. Siret D, Bretadeau G, Branger B, et al. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10 year retrospective study in a French region (Brittany). Pediatr Pulmonol 2003; 35:342-349.
13. Sims EJ, McCormick J, Mehta G, Mehta A. Newborn screening is associated with reduced treatment intensity. J Pediatr 2005; 147:306-311.
14. Sims EJ, Mugford M, Clark A, et al. UK Cystic Fibrosis Database Steering Committee. Economic implications of newborn screening for cystic fibrosis: A cost of illness retrospective cohort study. Lancet 2007; 369:1187-1195.
15. Ranganathan S, Dezateux C, Bush A, et al. Airway function in infants newly diagnosed with cystic fibrosis [research letter]. Lancet 2001; 358:1964-1965.
16. Khan TZ, Wagener JS, Bost T, et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151:1075-1082.
17. Kirchner KK, Wagener JS, Khan TZ, et al. Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis. Am J Respir Crit Care Med 1996; 154:1426-1429.
18. Nixon GM, Armstrong DS, Carzino R, et al. Early airway infection, inflammation, and lung function in cystic fibrosis. Arch Dis Child 2002; 87:306-311.
19. Armstrong DS, Hook SM, Jamsen KM, et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 2005; 40:500-510.
20. Stafler P, Davies JC, Balfour-Lynn IM, et al. Bronchoscopy in cystic fibrosis infants diagnosed by newborn screening. Pediatr Pulmonol 2011; 46:696-700.
21. Ranganathan SC, Stocks J, Dezateux C, et al. The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2004; 169:928-933.
22. Nielsen KG, Pressler T, Klug B, et al. Serial lung function and responsiveness in cystic fibrosis during early childhood. Am J Respir Crit Care Med 2004; 169:1209-1216.
23. Kozlowska WJ, Bush A, Wade A, et al. Lung function from infancy to the preschool years following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2008; 178:42-49.
24. Ranganathan S, Bush A, Dezateux C, et al. Relative ability of full and partial forced expiratory manoeuvres to identify diminished airway function in infants with cystic fibrosis. Am J Respir Crit Care Med 2002; 166:1350-1357.
25. Aurora P, Stocks J, Oliver C, et al., On behalf of LCCF. Quality control for spirometry in preschool children with and without lung disease. Am J Respir Crit Care Med 2004; 169:1152-1159.
26. Lum S, Stocks J, Stanojevic S, et al. Age and height dependence of lung clearance index and functional residual capacity. Eur Respir J 2013; 41:1371-1377.
27. Verbanck S, Thompson BR, Schuermans D, et al. Ventilation heterogeneity in the acinar and conductive zones of the normal ageing lung. Thorax 2012; 67:789-795.
28. Robinson PD, Latzin P, Verbanck S, et al. Consensus statement for inert gas washout measurement using multiple-And single-breath tests. Eur Respir J 2013; 41:507-522.
29. Bush A, Irving S. Wavering in the breeze: is multiple breath washout useful in primary ciliary dyskinesia? Thorax 2015; 70:305-306.
30. Singer F, Yammine S, Schmidt A, et al. Ventilatory response to nitrogen multiple-breath washout in infants. Pediatr Pulmonol 2014; 49: 342-347.
31. Hannon D, Bradley JM, Bradbury I, et al. Shortened Lung Clearance Index is a repeatable and sensitive test in children and adults with cystic fibrosis. Br Med J Open Respir Res 2014; 1:e000031.
32. Yammine S, Singer F, Abbas C, et al. Multiple-breath washout measurements can be significantly shortened in children. Thorax 2013; 68:586-587.
33. Stanojevic S, Jensen R, Sundaralingam D, et al. Alternative outcomes for the multiple breath washout in children with CF. J Cyst Fibros 2015; 14:490-496.
34. Robinson PD, Stocks J, Aurora P, Lum S. Abbreviated multibreath washout for calculation of lung clearance index. Pediatr Pulmonol 2013; 48: 336-343.
35. Aurora P, Gustafsson P, Bush A, et al. Multiple inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004; 59:1068-1073.
36. Aurora P, Bush A, Gustafsson P, et al. Multiple breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005; 171:249-256.
37. Kraemer R, Blum A, Schibler A, et al. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005; 171:371-378.
38. Lum S, Gustafsson P, Ljungberg H, et al. Early detection of cystic fibrosis lung disease: multiple-breath washout vs. raised volume tests. Thorax 2007; 62:341-347.
39. Aurora P, Stanojevic S, Wade A, et al., Stocks J; On behalf of the London CF Collaboration. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2011; 183:752-758.
40. Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008; 63:129-134.
41. Owens CM, Aurora P, Stanojevic S, et al., On behalf of the London Cystic Fibrosis Collaboration. Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 2011; 66:481-488.
42. Vermeulen F, Proesmans M, Boon M, et al. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis. Thorax 2014; 69:39-45.
43. FitzGerald JM. Targeting lung attacks. Thorax 2011; 66:365-366.
44. Bush A, Pavord I. Following Nero: fiddle while Rome burns, or is there a better way? Thorax 2011; 66:367.
45. Horsley AR, Davies JC, Gray RD, et al. Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 2013; 68:532-539.
46. Amin R, Subbarao P, Lou W, et al. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J 2011; 37:806-812.
47. Amin R, Subbarao P, Jabar A, et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010; 65:379-383.
48. Subbarao P, Stanojevic S, Brown M, et al. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 2013; 188:456-460.
49. Davies J, Sheridan H, Bell N, et al. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D CFTR mutation and preserved spirometry: A randomised controlled trial. Lancet Respir Med 2013; 1:630-638.
50. Morgan WJ, Stern DA, Sherrill DL, et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med 2005; 172:1253-1258.
51. Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: A nonselective longitudinal cohort study. Lancet 2007; 370:758-764.
52. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349:1414-1422.
53. Tai A, Tran H, Roberts M, et al. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax 2014; 69:805-810.
54. Hoo A-F, Thia P, Nguyen TTD, et al. Lung function is abnormal in 3 month old infants with cystic fibrosis diagnosed by newborn screening. Thorax 2012; 67:874-881.
55. Thanh-Diem N, P Thia LP, Hoo A-F, et al., On behalf of the London Cystic Fibrosis Collaboration (LCFC). Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax 2014; 69:910-917.
56. Thia LP, Calder A, Stocks J, et al., On behalf of the London Cystic Fibrosis Collaboration (LCFC). Original article: is chest CT useful in newborn screened infants with cystic fibrosis at 1year of age? Thorax 2014; 69:320-327.
57. Brenan LC, Thia LP, Hoo A-F, et al. Evolution of lung function during the first two years of life in infants with cystic fibrosis diagnosed by newborn screening. Thorax 2013; 68 (Suppl 111):A6-A7.
58. Ranganathan SC, Parsons F, Gangell C, et al. Australian Respiratory Early Surveillance Team for Cystic Fibrosis. Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis. Thorax 2011; 66:408-413.
59. Linnane BM, Hall GL, Nolan G, et al. AREST-CF. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008; 178:1238-1244.
60. Pillarisetti N, Williamson E, Linnane B, et al. Australian Respiratory Early Surveillance Team for Cystic Fibrosis(AREST CF). Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 2011; 184:75-81.
61. Ramsey KA, Ranganathan S, Park J, et al. Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med 2014; 190:1111-1116.
62. Gangell C, Gard S, Douglas T, et al. AREST-CF. Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis. Clin Infect Dis 2011; 53:425-432.
63. Hall GL, Logie KM, Parsons F, et al. Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening. PLoS One 2011; 6:e23932.
64. Mott LS, Park J, Murray CP, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012; 67:509-516.
65. Mott LS, Graniel KG, Park J, et al. Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume. Chest 2013; 144:1193-1198.
66. Sly PD, Gangell CL, Chen L, et al. Investigators. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 2013; 368:1963-1970.
67. Mott LS, Park J, Gangell CL, et al. Australian Respiratory Early Surveillance Team for Cystic Fibrosis Study Group. Distribution of early structural lung changes due to cystic fibrosis detected with chest computed tomography. J Pediatr 2013; 163:243-248.
68. Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol 2003; 47:215-220.
69. Crowley S, Matthews I. Resolution of extensive severe bronchiectasis in an infant. Pediatr Pulmonol 2010; 45:717-720.
70. Rosenow T, Oudraad MC, Murray CP, et al. PRAGMA-CF: A quantitative structural lung disease CT outcome in young children with cystic fibrosis. Am J Respir Crit Care Med 2015; 191:1158-1165.
71. Goris ML, Zhu HJ, Blankenberg F, et al. An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 2003; 123:1655-1663.
72. Wainwright CE, Vidmar S, Armstrong DS, et al. Tiddens HA; ACFBAL Study Investigators. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: A randomized trial. J Am Med Assoc 2011; 306:163-171.
73. Maisonneuve P, Marshall BC, Knapp EA, Lowenfels AB. Cancer risk in cystic fibrosis: A 20-year nationwide study from the United States. J Natl Cancer Inst 2013; 105:122-129.